Effect of PaCO2 and PaO2 on lidocaine and articaine toxicity
- PMID: 20843225
- PMCID: PMC3315279
- DOI: 10.2344/0003-3006-57.3.104
Effect of PaCO2 and PaO2 on lidocaine and articaine toxicity
Abstract
Alterations in arterial PaCO₂ can influence local anesthetic toxicity. The objective of this study was to evaluate the effect of stress-induced changes in PaCO₂ and PaO₂ on the seizure threshold of lidocaine and articaine. Lidocaine (2% with 1 : 100,000 epinephrine) or articaine (4% with 1 : 100,000 epinephrine) was administered intravenously under rest or stress conditions to 36 rats separated into 4 groups. Propranolol and prazosin were administered preoperatively to minimize cardiovascular effects of epinephrine. Mean arterial pressure (MAP), heart rate (HR), and arterial pH, PaCO₂, and PaO₂ were measured. Results showed no differences in MAP, HR, or pH. Stress significantly increased the latency period for the first tonic-clonic seizure induced by a toxic dose of both lidocaine and articaine (P < .05). Seizures were brought on more rapidly by articaine. No significant difference between toxic doses of lidocaine and articaine was noted. Stress raised the seizure threshold dose for both drugs and significantly (P < .01) increased arterial PaO₂ from 94.0 ± 1.90 mm Hg to 113.0 ± 2.20 mm Hg, and reduced PaCO₂ from 36.0 ± 0.77 mm Hg to 27.0 ± 0.98 mm Hg. In conclusion, reduction in PaCO₂ and/or increase in PaO₂ raised the seizure threshold of lidocaine and articaine. This study also confirmed that lidocaine and articaine have equipotent central nervous system toxicity.
Figures



Similar articles
-
Comparison of injection pain, heart rate increase, and postinjection pain of articaine and lidocaine in a primary intraligamentary injection administered with a computer-controlled local anesthetic delivery system.Anesth Prog. 2004;51(4):126-33. Anesth Prog. 2004. PMID: 15675261 Free PMC article. Clinical Trial.
-
Effect of articaine on mental nerve anterior portion: histological analysis in rats.Acta Odontol Scand. 2013 Jan;71(1):82-7. doi: 10.3109/00016357.2011.654243. Epub 2012 Mar 29. Acta Odontol Scand. 2013. PMID: 22458536
-
Efficacy of articaine and lidocaine in a primary intraligamentary injection administered with a computer-controlled local anesthetic delivery system.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Mar;99(3):361-6. doi: 10.1016/j.tripleo.2004.11.009. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005. PMID: 15716846 Clinical Trial.
-
Comparison of articaine and lidocaine in the pediatric population.J Mich Dent Assoc. 2014 Jan;96(1):34-7. J Mich Dent Assoc. 2014. PMID: 24654413 Review.
-
Efficacy of articaine formulations: quantitative reviews.Dent Clin North Am. 2010 Oct;54(4):643-53. doi: 10.1016/j.cden.2010.06.005. Dent Clin North Am. 2010. PMID: 20831928 Review.
Cited by
-
In relation to NO-System, Stable Pentadecapeptide BPC 157 Counteracts Lidocaine-Induced Adverse Effects in Rats and Depolarisation In Vitro.Emerg Med Int. 2020 May 27;2020:6805354. doi: 10.1155/2020/6805354. eCollection 2020. Emerg Med Int. 2020. PMID: 32566305 Free PMC article.
References
-
- De Toledo J.C. Lidocaine and seizures. Ther Drug Monit. 2000;22:320–322. - PubMed
-
- Baluga J.C, Casamayou R, Carozzi E, et al. Allergy to local anaesthetics in dentistry. Myth or reality. Allergol Immunopathol. 2002;30:14–19. - PubMed
-
- Finucane B.T. Allergies to local anesthetics—the real truth. Can J Anesth. 2003;50:869–874. - PubMed
-
- Aps C, Reynolds F. The effect of concentration on vasoactivity of bupivacaine and lignocaine. Br J Anaesth. 1976;48:1171–1174. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources